Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia

被引：63
作者：
Kantarjian, Hagop [1 ]
Thomas, Deborah
Wayne, Alan S. [2 ]
O'Brien, Susan
机构：
[1] Univ Texas MD Anderson Canc Ctr, Leukemia Dept, Houston, TX 77030 USA
[2] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 31期
基金：
美国国家卫生研究院;
关键词：
ACUTE LYMPHOCYTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; HYPER-CVAD; INOTUZUMAB OZOGAMICIN; HEMATOLOGIC MALIGNANCIES; GEMTUZUMAB OZOGAMICIN; PEDIATRIC-PATIENTS; ADULT PATIENTS; RITUXIMAB; CHEMOTHERAPY;
D O I：
10.1200/JCO.2012.41.6768
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：3876 / 3883
页数：8
相关论文
共 69 条
  • [1] Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study
    Advani, Anjali
    Coiffier, Bertrand
    Czuczman, Myron S.
    Dreyling, Martin
    Foran, James
    Gine, Eva
    Gisselbrecht, Christian
    Ketterer, Nicolas
    Nasta, Sunita
    Rohatiner, Ama
    Schmidt-Wolf, Ingo G. H.
    Schuler, Martin
    Sierra, Jorge
    Smith, Mitchell R.
    Verhoef, Gregor
    Winter, Jane N.
    Boni, Joseph
    Vandendries, Erik
    Shapiro, Mark
    Fayad, Luis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (12) : 2085 - 2093
  • [2] A Phase II Study of Campath-1H in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia: A Children's Oncology Group Report
    Angiolillo, Anne L.
    Yu, Alice L.
    Reaman, Gregory
    Ingle, Ashish M.
    Secola, Rita
    Adamson, Peter C.
    [J]. PEDIATRIC BLOOD & CANCER, 2009, 53 (06) : 978 - 983
  • [3] [Anonymous], BLOOD
  • [4] Modern Therapy of Acute Lymphoblastic Leukemia
    Bassan, Renato
    Hoelzer, Dieter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (05) : 532 - 543
  • [5] Chemotherapy-Phased Imatinib Pulses Improve Long-Term Outcome of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Northern Italy Leukemia Group Protocol 09/00
    Bassan, Renato
    Rossi, Giuseppe
    Pogliani, Enrico M.
    Di Bona, Eros
    Angelucci, Emanuele
    Cavattoni, Irene
    Lambertenghi-Deliliers, Giorgio
    Mannelli, Francesco
    Levis, Alessandro
    Ciceri, Fabio
    Mattei, Daniele
    Borlenghi, Erika
    Terruzzi, Elisabetta
    Borghero, Carlo
    Romani, Claudio
    Spinelli, Orietta
    Tosi, Manuela
    Oldani, Elena
    Intermesoli, Tamara
    Rambaldi, Alessandro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) : 3644 - 3652
  • [6] SAR3419: An Anti-CD19-Maytansinoid Immunoconjugate for the Treatment of B-Cell Malignancies
    Blanc, Veronique
    Bousseau, Anne
    Caron, Anne
    Carrez, Chantal
    Lutz, Robert J.
    Lambert, John M.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (20) : 6448 - 6458
  • [7] Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
    Brüggemann, M
    Raff, T
    Flohr, T
    Gökbuget, N
    Nakao, M
    Droese, J
    Lüschen, S
    Pott, C
    Ritgen, M
    Scheuring, U
    Horst, HA
    Thiel, E
    Hoelzer, D
    Bartram, CR
    Kneba, M
    [J]. BLOOD, 2006, 107 (03) : 1116 - 1123
  • [8] Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
    Cheson, Bruce D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3525 - 3530
  • [9] Claviez A, 2006, HAEMATOL-HEMATOL J, V91, P272
  • [10] Coiffier B, 2011, J CLIN ONCOL S15, V29, p508s
1234567